Qi Ling
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Transplantation top 5%
Papers in
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Liver physiology and pathology 5
- Surgery 37
- Organ Transplantation Techniques and Outcomes 34
- Co-authors
- Xiao Xu (43 shared papers)Shusen Zheng (47 shared papers)Haiyang Xie (33 shared papers)Xuyong Wei (17 shared papers)Lin Zhou (15 shared papers)Ruihan Chen (10 shared papers)Feng Gao (9 shared papers)Hong Zhu (3 shared papers)
In The Last Decade
Qi Ling
104 papers receiving 2.8k citations
Qi Ling's Hit Papers
Peers
Comparison fields: 5 of 93
- Hepatology 744
- Transplantation 53
- Cancer Research 204
- Epidemiology 476
- Surgery 460
Countries citing papers authored by Qi Ling
This map shows the geographic impact of Qi Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Ling more than expected).
Fields of papers citing papers by Qi Ling
This network shows the impact of papers produced by Qi Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Ling. The network helps show where Qi Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis Hit paper breakdown → | 2019 | 641 |
| 2 | 2015 | 223 | |
| 3 | 2015 | 133 | |
| 4 | 2021 | 101 | |
| 5 | 2011 | 83 | |
| 6 | 2023 | 83 | |
| 7 | 2022 | 76 | |
| 8 | 2023 | 54 | |
| 9 | 2015 | 44 | |
| 10 | 2013 | 43 | |
| 11 | 2014 | 43 | |
| 12 | 2014 | 42 | |
| 13 | 2024 | 42 | |
| 14 | 2017 | 41 | |
| 15 | 2015 | 36 | |
| 16 | 2016 | 33 | |
| 17 | 2019 | 33 | |
| 18 | Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. | 2009 | 32 |
| 19 | 2022 | 32 | |
| 20 | 2014 | 31 |
About Qi Ling
Qi Ling is a scholar working on Hepatology, Surgery, Cancer Research, Molecular Biology and Oncology, having authored 105 papers that have together received 2.9k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), MicroRNA in disease regulation (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Hepatitis B Virus Studies (5 papers), Liver physiology and pathology (5 papers), Gut microbiota and health (5 papers) and Mechanisms of cancer metastasis (4 papers). The work is most often cited by research in Hepatology (744 citations), Transplantation (53 citations), Cancer Research (204 citations), Epidemiology (476 citations) and Surgery (460 citations). Qi Ling has collaborated with scholars based in China, Canada and Germany. Frequent co-authors include Xiao Xu, Shusen Zheng, Haiyang Xie, Xuyong Wei, Lin Zhou, Ruihan Chen, Feng Gao, Hong Zhu, Runzhou Zhuang and Di Lu. Their work appears in journals such as Liver International, Transplantation, Scientific Reports, PLoS ONE and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.